Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

Published:2013-09 Issue:9 Volume:15 Page:1062-1073
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

McMurray John J. V.¹,Packer Milton²,Desai Akshay S.³,Gong Jim⁴,Lefkowitz Martin P.⁴,Rizkala Adel R.⁴,Rouleau Jean⁵,Shi Victor C.⁴,Solomon Scott D.³,Swedberg Karl⁶,Zile Michael R.⁷,

Affiliation:

1. BHF Cardiovascular Research Centre; University of Glasgow; Glasgow UK

2. University of Texas Southwestern Medical Center; Dallas TX USA

3. Brigham and Women's Hospital; Cardiovascular Medicine; MA USA

4. Novartis Pharmaceutical Corporation; East Hanover NJ USA

5. Université de Montréal; Institut de Cardiologie; Montréal Canada

6. University of Gothenburg; Cardiovascular Medicine Department; Gothenburg Sweden

7. The Medical University of South Carolina and RHJ Department of Veterans Administration Medical center; Charleston SC USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hft052/fullpdf

Reference46 articles.

1. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure;Packer;J Am Coll Cardiol,1992

2. Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies;Swedberg;Eur J Heart Fail,2000

3. Beta-blockade in the management of chronic heart failure. Another step in the conceptual evolution of a neurohormonal model of the disease;Packer;Eur Heart J,1996

4. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure;McMurray;Eur J Heart Fail,2011

5. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure;Shibata;Eur J Heart Fail,2001

Cited by 357 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy;Journal of Molecular and Cellular Cardiology Plus;2024-03

2. Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure;European Journal of Heart Failure;2024-01-15

3. Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review;Biomedicines;2024-01-15

4. ΔRDW Could Predict Major Adverse Cardiovascular Events in Patients with Heart Failure with Reduced Ejection Fraction After Sacubitril/Valsartan Treatment;International Journal of General Medicine;2023-12

5. The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?;Journal of Cardiovascular Development and Disease;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3